Antibodies to myelin oligodendrocyte glycoprotein are not involved in the severity of chronic non-remitting experimental autoimmune encephalomyelitis

Immunology Letters

Volumn 122, Issue 2, 2009, Pages 145-149

  Sekiguchi, Yukio ^a   Ichikawa, Motoki ^b   Takamoto, Masaya ^c   Ota, Hiroyoshi ^b   Koh, Chang Sung ^b   Muramatsu, Masamichi ^d   Honjo, Tasuku ^e   Agematsu, Kazunaga ^c  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b SHINSHU UNIVERSITY   (Japan)

^c SHINSHU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d KANAZAWA UNIVERSITY   (Japan)

^e KYOTO UNIVERSITY   (Japan)

Author keywords

Activation induced cytidine deaminase; Experimental autoimmune encephalomyelitis; Myelin oligodendrocyte glycoprotein

Indexed keywords

ACTIVATION INDUCED CYTIDINE DEAMINASE; ANTIBODY; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MYELIN OLIGODENDROCYTE GLYCOPROTEIN;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; BLOOD SAMPLING; C57BL 6 MOUSE; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SOMATIC MUTATION; SPLEEN CELL; T LYMPHOCYTE; TH1 CELL; TRANSGENIC MOUSE;

ANIMALS; ANTIBODY FORMATION; CELL PROLIFERATION; CHRONIC DISEASE; CYTIDINE DEAMINASE; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; GLYCOPROTEINS; IMMUNOGLOBULIN CLASS SWITCHING; IMMUNOGLOBULIN G; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYELIN-ASSOCIATED GLYCOPROTEIN; PEPTIDE FRAGMENTS; SOMATIC HYPERMUTATION, IMMUNOGLOBULIN; T-LYMPHOCYTE SUBSETS; TH1 CELLS;

EID: 62649101910     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imlet.2008.08.009     Document Type: Article

References (41)

1. Bernard C.C.A., Ichikawa M., Johns T.G., Menon K., and Slavin A. Autoantigens in experimental autoimmune encephalomyelitis and multiple sclerosis. In: Abramsky O., and Ovadia H. (Eds). Frontiers in multiple sclerosis: clinical research and therapy (1997), Martin Dunitz, London 61-70
2. Wekerle H., Kojima K., Lannes-Vieira J., Lassmann H., and Linington C. Animal models. Ann Neurol 36 (1994) S47-S53
3. Bernard C.C., Johns T.G., Slavin A., Ichikawa M., Ewing C., Liu J., et al. Myelin oligodendrocyte glycoprotein: a novel candidate autoantigen in multiple sclerosis. J Mol Med 75 (1997) 77-88
4. Schluesener H.J. T cell line-mediated EAE: prevention and therapy by a monoclonal antibody specific for T lymphoblasts. J Neuroimmunol 14 (1987) 339-343
5. Linington C., Bradl M., Lassmann H., Brunner C., and Vass K. Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin/oligodendrocyte glycoprotein. Am J Pathol 130 (1988) 443-454
6. Linington C., Engelhardt B., Kapocs G., and Lassman H. Induction of persistently demyelinated lesions in the rat following the repeated adoptive transfer of encephalitogenic T cells and demyelinating antibody. J Neuroimmunol 40 (1992) 219-224
7. Kerlero de Rosbo N., Honegger P., Lassmann H., and Matthieu J.M. Demyelination induced in aggregating brain cell cultures by a monoclonal antibody against myelin/oligodendrocyte glycoprotein. J Neurochem 55 (1990) 583-587
8. + MOG-specific T cells on oligomeric MHC class I molecules. Int Immunol 15 (2003) 261-268
9. Klinkert W.E., Kojima K., Lesslauer W., Rinner W., Lassmann H., and Wekerle H. TNF-α receptor fusion protein prevents experimental auto-immune encephalomyelitis and demyelination in Lewis rats: an overview. J Neuroimmunol 72 (1997) 163-168
10. Becher B., Durell B.G., and Noelle R.J. Experimental autoimmune encephalitis and inflammation in the absence of interleukin-12. J Clin Invest 110 (2002) 493-497
11. Cua D.J., Sherlock J., Chen Y., Murphy C.A., Joyce B., Seymour B., et al. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 421 (2003) 744-748
12. Langrish C.L., Chen Y., Blumenschein W.M., Mattson J., Basham B., Sedgwick J.D., et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 201 (2005) 233-240
13. Berger T., Rubner P., Schautzer F., Egg R., Ulmer H., Mayringer I., et al. Antimyelin antibodies as a predictor of clinically definite multiple sclerosis after a first demyelinating event. N Engl J Med 349 (2003) 139-145
14. Lyons J.A., San M., Happ M.P., and Cross A.H. B cells are critical to induction of experimental allergic encephalomyelitis by protein but not by a short encephalitogenic peptide. Eur J Immunol 29 (1999) 3432-3439
15. Svensson L., Abdul-Majid K.B., Bauer J., Lassmann H., Harris R.A., and Holmdahl R. A comparative analysis of B cell-mediated myelin oligodendrocyte glycoprotein-experimental autoimmune encephalomyelitis pathogenesis in B cell-deficient mice reveals an effect on demyelination. Eur J Immunol 32 (2002) 1939-1946
16. Wolf S.D., Dittel B.N., Hardardottir F., and Janeway Jr. C.A. Experimental autoimmune encephalomyelitis induction in genetically B cell-deficient mice. J Exp Med 184 (1996) 2271-2278
17. Hjelmstrom P., Juedes A.E., Fjell J., and Ruddle N.H. B-cell-deficient mice develop experimental allergic encephalomyelitis with demyelination after myelin oligodendrocyte glycoprotein sensitization. J Immunol 161 (1998) 4480-4483
18. Dittel B.N., Urbania T.H., and Janeway Jr. C.A. Relapsing and remitting experimental autoimmune encephalomyelitis in B cell deficient mice. J Autoimmun 14 (2000) 311-318
19. Fillatreau S., Sweenie C.H., McGeachy M.J., Gray D., and Anderton S.M. B cells regulate autoimmunity by provision of IL-10. Nat Immunol 3 (2002) 944-950
20. Komiyama Y., Nakae S., Matsuki T., Nambu A., Ishigame H., Kakuta S., et al. IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J Immunol 177 (2006) 566-573
21. Chen Y., Langrish C.L., McKenzie B., Joyce-Shaikh B., Stumhofer J.S., McClanahan T., et al. Anti-IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitis. J Clin Invest 116 (2006) 1317-1326
22. Litzenburger T., Fässler R., Bauer J., Lassmann H., Linington C., Wekerle H., et al. B lymphocytes producing demyelinating autoantibodies: development and function in gene-targeted transgenic mice. J Exp Med 188 (1998) 169-180
23. Bettelli E., Baeten D., Jager A., Sobel R.A., and Kuchroo V.K. Myelin oligodendrocyte glycoprotein-specific T and B cells cooperate to induce a Devic-like disease in mice. J Clin Invest 116 (2006) 2393-2402
24. -/- mice in the absence of elevated proinflammatory cytokine response in the central nervous system. J Immunol 168 (2002) 3105-3112
25. Muramatsu M., Kinoshita K., Fagarasan S., Yamada S., Shinkai Y., and Honjo T. Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell 102 (2000) 553-563
26. Muramatsu M., Nagaoka H., Shinkura R., Begum N.A., and Honjo T. Discovery of activation-induced cytidine deaminase, the engraver of antibody memory. Adv Immunol 94 (2007) 1-36
27. Muramatsu M., Sankaranand V.S., Anant S., Sugai M., Kinoshita K., Davidson N.O., et al. Specific expression of activation-induced cytidine deaminase (AID), a novel member of the RNA-editing deaminase family in germinal center B cells. J Biol Chem 274 (1999) 18470-18476
28. - naive B cells. Blood 99 (2002) 567-575
29. Ichikawa M., Koh C.S., Inaba Y., Seki C., Inoue A., Itoh M., et al. IgG subclass switching is associated with the severity of experimental autoimmune encephalomyelitis induced with myelin oligodendrocyte glycoprotein peptide in NOD mice. Cell Immunol 191 (1999) 97-104
30. Sekiguchi Y., Ichikawa M., Inoue A., Itoh M., and Koh C.S. Brain-derived gangliosides suppress the chronic relapsing-remitting experimental autoimmune encephalomyelitis in NOD mice induced with myelin oligodendrocyte glycoprotein peptide. J Neuroimmunol 116 (2001) 196-205
31. Ichikawa M., Johns T.G., Liu J., and Bernard C.C. Analysis of the fine B cell specificity during the chronic/relapsing course of a multiple sclerosis-like disease in Lewis rats injected with the encephalitogenic myelin oligodendrocyte glycoprotein peptide 35-55. J Immunol 157 (1996) 919-926
32. Cross A.H., Trotter J.L., and Lyons J. B cells and antibodies in CNS demyelinating disease. J Neuroimmunol 112 (2001) 1-14
33. Gausas J., Paterson P.Y., Day E.D., and Dal Canto M.C. Intact B-cell activity is essential for complete expression of experimental allergic encephalomyelitis in Lewis rats. Cell Immunol 72 (1982) 360-366
34. Willenborg D.O., and Prowse S.J. Immunoglobulin-deficient rats fail to develop experimental allergic encephalomyelitis. J Neuroimmunol 5 (1983) 99-109
35. Gardinier M.V., and Matthieu J.M. Cloning and cDNA sequence analysis of myelin/oligodendrocyte glycoprotein: a novel member of the immunoglobulin gene superfamily. Schweiz Arch Neurol Psychiatr 144 (1993) 201-207
36. Genain C.P., Abel K., Belmar N., Villinger F., Rosenberg D.P., Linington C., et al. Late complications of immune deviation therapy in a nonhuman primate. Science 274 (1996) 2054-2057
37. Ren C.L., Morio T., Fu S.M., and Geha R.S. Signal transduction via CD40 involves activation of lyn kinase and phosphatidylinositol-3-kinase, and phosphorylation of phospholipase Cγ2. J Exp Med 179 (1994) 673-680
38. Piddlesden S.J., Lassmann H., Zimprich F., Morgan B.P., and Linington C. The demyelinating potential of antibodies to myelin oligodendrocyte glycoprotein is related to their ability to fix complement. Am J Pathol 143 (1993) 555-564
39. Piddlesden S., Lassmann H., Laffafian I., Morgan B.P., and Linington C. Antibody-mediated demyelination in experimental allergic encephalomyelitis is independent of complement membrane attack complex formation. Clin Exp Immunol 83 (1991) 245-250
40. Harada Y., Muramatsu M., Shibata T., Honjo T., and Kuroda K. Unmutated immunoglobulin M can protect mice from death by influenza virus infection. J Exp Med 197 (2003) 1779-1785
41. Revy P., Muto T., Levy Y., Geissmann F., Plebani A., Sanal O., et al. Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2). Cell 102 (2000) 565-575